Search Medical Condition
Please enter condition
Please choose location

Latham, New York Clinical Trials

A listing of Latham, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (151) clinical trials

Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis

This is a randomized, double-blind, double-dummy, active comparator-controlled, parallel-group, multi-center study with variable treatment duration in approximately 900 patients with relapsing MS. The maximal treatment duration in the study for an individual patient will be 2.5 years. Eligible patients will be randomized to receive either experimental ofatumumab subcutaneous (sc) injections ...

Phase

0.0 miles

Learn More »

This clinical trial is provided by Antidote. Researchers have recently begun testing the idea that patients with early Alzheimer's disease are more likely to benefit from treatment than those with more advanced disease. This study is testing how well a potential new treatment works to reverse the symptoms of early ...

Phase

0.0 miles

Learn More »

This clinical trial is provided by Antidote. Include potential benefits for the volunteers here when signing up for this trial registry. (512 characters available)

Phase

0.0 miles

Learn More »

This clinical trial is provided by Antidote. Mild cognitive impairment (MCI) refers to problems with memory and thinking that go beyond normal aging, but do not interfere with daily life. MCI is associated with a higher risk of developing Alzheimer’s disease. Clinical trials are currently testing if treatments can slow ...

Phase

0.0 miles

Learn More »

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Oversight Authorities continued: Colombia- pending regulatory approval

Phase

0.17 miles

Learn More »

A Study of Apixaban in Patients With Atrial Fibrillation Not Caused by a Heart Valve Problem Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Patients will be recruited from either inpatient coronary care or general medical units, or recruited from outpatient cardiology offices. Masking: Apixaban: Open label. VKA: Open label. Acetylsalicylic acid film coated tablet: Double Blinded. Placebo matching Acetylsalicylic acid film coated tablet: Double Blinded.

Phase

2.36 miles

Learn More »

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

This is an international, multicentre, parallel group, event-driven, randomized, double-blind, placebo-controlled study in patients with chronic heart failure with reduced ejection fraction (HFrEF), evaluating the effect of dapagliflozin versus placebo, given once daily in addition to background regional standard of care therapy, for the prevention of cardiovascular (CV) death or ...

Phase

2.36 miles

Learn More »